Robot maker · registered
Cornerstone Robotics
Sentire® Endoscopic Surgical System with in-house Cspeed Vision 3D imaging (HD 3D, 10× magnification), multi-DOF robotic arms with tremor filtration, and AI-assisted motion control for confined anatomical spaces; surgeon-directed teleoperated system for laparoscopic procedures in urology, gynecology, general surgery, and thoracic surgery; remote-surgery research collaboration with Imperial College London.
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
Sentire Endoscopic Surgical System
- Indicated for urology, general surgery (GI/HBP), gynecology, and thoracic procedures; multi-specialty endoscopic surgical platform
vendor-defined surgical specialties and indication scope
Claim source - NMPA (China) approval 2024; CE Mark (MDR) and Singapore HSA dual certification May 2026
regulatory clearances achieved across markets
Claim source - World's first clinical validation of autonomous surgery using embodied intelligence platform published in Science Robotics (August 2025, CUHK collaboration)
peer-reviewed autonomous surgery milestone
Claim source
Deployment log
Announced and cited only
Funding history
Publicly announced rounds
Growth
Daohe Investment, Gaorong Capital, Hong Kong Investment Corporation, Qiming Venture Partners, ZhenFund
Round sourceSeries C
Alpha JWC Ventures, China TsingSong Capital, eGarden Ventures, EQT, Innovation and Technology Venture Fund, K2VC, Long-Z Capital, Qiming Venture Partners
Round sourceSeries B
China TsingSong Capital, DragonBall Capital, Gaorong Capital, K2VC, Lilly Asia Ventures, New World Development Group, Qiming Venture Partners
Round sourceCompany timeline
Milestones and announcements
Source ledger
14 unique public sources